Status:
UNKNOWN
The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Diabetes Mellitus Type II
Eligibility:
All Genders
30-65 years
Phase:
PHASE4
Brief Summary
The aim of this study is to determine the effects of supplementation with n-3 fatty acid or placebo for 10 weeks on the expression of Sirt-1, AdipoR1 \& AdipoR2 genes in the peripheral blood mononucle...
Detailed Description
The aim of this study is to determine of the effects of supplementation with n-3 fatty acid or placebo for 10 weeks on the expression of Sirt-1, AdipoR1(adiponectin receptor 1) \& AdipoR2 (adiponectin...
Eligibility Criteria
Inclusion
- willingness to participation,
- diabetic patients 30- 60 years old,
- body mass index in the range 25-40,
- avoidance of dietary supplements,
- vitamins and herbal products at least 3 months before and throughout the intervention
Exclusion
- people who have used n-3 Fatty Acid Supplementation in last 3 months,
- having chronic renal disease ,
- GI disease,
- Hepatobiliary diseases,
- hematological disorders,
- hypo- or hyperthyroidism,
- type 1 diabetes,
- treatment with orlistat or sibutramine for weight loss,
- pregnancy and lactation,
- treatment with insulin or Thiazolidinediones.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2016
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT02261545
Start Date
September 1 2014
End Date
February 1 2016
Last Update
November 18 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.